Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing

1. Congresswoman Donna M. Christensen, M.D.

Chair, Congressional Black Caucus [CBC]

1. Congresswoman Donna M. Christensen, M.D.

Chair, Congressional Black Caucus [CBC]

Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005

Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing

2. Gary A. Puckrein, Ph.D.National Minority Health Month Foundation

2. Gary A. Puckrein, Ph.D.National Minority Health Month Foundation

Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005

Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing

3. B. Waine Kong, J.D., Ph.D.CEO – American Association of Black Cardiologists [ABC]

3. B. Waine Kong, J.D., Ph.D.CEO – American Association of Black Cardiologists [ABC]

Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005

Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing

4. Debra Lee

4. Debra Lee

Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005

Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing

5. Shomarka Omar Y. Keita, M.D., D.Phil.Medical Officer - Department of Human Services, District of ColumbiaResearch Associate - Anthropology Department, Smithsonian Institution

5. Shomarka Omar Y. Keita, M.D., D.Phil.Medical Officer - Department of Human Services, District of ColumbiaResearch Associate - Anthropology Department, Smithsonian Institution

Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005

Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing

6. Jonathan Kahn, J.D., Ph.D.Assistant ProfessorHamline University School of Law

6. Jonathan Kahn, J.D., Ph.D.Assistant ProfessorHamline University School of Law

Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005

Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing

7. Charles L. Curry, M.D., FACC, FACPPresident - International Society on Hypertension in Blacks

7. Charles L. Curry, M.D., FACC, FACPPresident - International Society on Hypertension in Blacks

Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005

Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing

8. Basil Halliday, M.Sc.

President & CEO - BDH Clinical Research Services

8. Basil Halliday, M.Sc.

President & CEO - BDH Clinical Research Services

Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005

Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing

9. Charles N. Rotimi, Ph.D.National Human Genome Center Howard University

9. Charles N. Rotimi, Ph.D.National Human Genome Center Howard University

Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005

Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing

10. Charmaine Royal, Ph.D.

National Human Genome CenterHoward University

10. Charmaine Royal, Ph.D.

National Human Genome CenterHoward University

Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005

Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing

11. Olivia Carter-Pokras, Ph.D.Associate Professor – University of Maryland, School of Medicine, Dept. of Epidemiology

11. Olivia Carter-Pokras, Ph.D.Associate Professor – University of Maryland, School of Medicine, Dept. of Epidemiology

Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005

Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing

12. Lucille C. Norville Perez, MDNational Health Director - National Associationfor the Advancement of Colored People

12. Lucille C. Norville Perez, MDNational Health Director - National Associationfor the Advancement of Colored People

Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005

Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing

13. Dianna Wells13. Dianna Wells

Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005